AbbVie (NYSE:ABBV - Get Rating) updated its fourth quarter 2022 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $3.51-$3.55 for the period, compared to the consensus estimate of $3.67. The company issued revenue guidance of -. AbbVie also updated its FY 2022 guidance to $13.70-$13.74 EPS.
https://www.marketbeat.com/instant-alerts/nyse-abbv-earnings-guidance-2023-01/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.